(EMAILWIRE.COM, August 09, 2018 ) Classification of blood on the basis of absence and presence of antibodies or inherited antigenic substances on the surface of red blood cells is termed as blood group typing. These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system.

Blood Group Typing market is anticipated to grow at 9.80% CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD 2.36 billion in 2018 and is expected to reach USD 3.77 billion by 2023.

Browse full report @ https://www.marketdataforecast.com/market-reports/blood-group-typing-market-6350/

The global market for molecular blood grouping is increasing significantly. The market has a lot of potential due to a growth in the demand for blood transfusion. For the purpose of transfusion, donor blood compatibility with recipient patient is highly important. Therefore, before transfusion of blood, in order to check compatibility, blood samples are cross-matched with each other. Transfusion of blood is usually safe; however, alloimmunization can create a complication in the recipient. The alloimmunization can be dreadful in patients’ suffering from diseases like sickle cell anemia. The molecular blood group typing is used to determine the presence of antigens in the red blood cells through testing. In general, A, B, and D (Rh) antigens are tested as part of standard procedure, followed by determination of other antigens if required. Reverse grouping confirms ABO blood group typing by detecting expected iso-agglutinins.

Request sample report @ https://www.marketdataforecast.com/market-reports/blood-group-typing-market-6350/request-sample

The global Blood Group Typing market is segmented on the basis of Technique, Product, Test Type, and End User. On the basis of Product, the market is segmented into Consumable, Instrument, and Service. Consumables segment is further segmented into anti-human globulin reagents, red blood cells reagents, antisera reagents, and blood bank saline. Consumables segment is expected to grow at the highest CAGR during the forecast period. The sudden rise in blood donation rates is another key factor driving the growth of this segment. On the basis of Test Type, the market is segmented into prestige ABO, Antigen, Antibody Screening, Cross Matching, and HLA. The antibody screening segment is projected to witness the highest CAGR in this market segment in the coming years due to the increasing prevalence of chronic disorders and growing demand for the early diagnosis of diseases. On the basis of Technique, the market is segmented into Assay, PCR, Microarray, and Massively Parallel Sequencing. The PCR-based and microarray techniques segment accounted for the largest share of this market segment and is further expected to grow at the highest CAGR during the forecast period due to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions. On the basis of End User, the market is segmented into Clinical Laboratories, Blood Banks, Hospitals, and Other End Users. The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period owing to an increase in the awareness among people regarding blood donations and its importance, rising number of blood donations, and growing requirement of blood in surgical treatments.

 

Inquire before buying @ https://www.marketdataforecast.com/market-reports/blood-group-typing-market-6350/inquire

On the basis of geography, the Blood Group Typing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America occupies the largest market share followed by Europe. The United States has been the major market across the world. Factors such as advanced technology, research, and development activities have boosted the North America market. Asia Pacific is expected to witness the highest CAGR during the forecast period due to the rising population, and an increase in disposable income. Furthermore, due to these factors, the Asian market is observing a high number of new entrants compared to those in developed regions.

Request discount @ https://www.marketdataforecast.com/market-reports/blood-group-typing-market-6350/request-discount

The market is dominated by companies like Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.

Buy full report @ https://www.marketdataforecast.com/cart/buy-now/blood-group-typing-market-6350

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results